Login

Astria Therapeutics, Inc. SEC Filings

Filed On Filing
17 Feb 2026 SCHEDULE 13G/A
12 Feb 2026 SCHEDULE 13G/A
09 Feb 2026 SCHEDULE 13D/A
02 Feb 2026 15-12G
28 Jan 2026 SCHEDULE 13D/A
27 Jan 2026 EFFECT
27 Jan 2026 EFFECT
27 Jan 2026 EFFECT
27 Jan 2026 EFFECT
27 Jan 2026 EFFECT
27 Jan 2026 EFFECT
26 Jan 2026 25-NSE/A
23 Jan 2026 Form 4: Lapointe Anthony Gregg, Director

Disposed of 79,749 Stock Option (Right to Buy) (Disposition to Issuer)

23 Jan 2026 Form 4: Violin Jonathan, Director

Returned 263,321 shares to the issuer · Acquired 77,249 Stock Option (Right to Buy) (Disposition to Issuer)

23 Jan 2026 Form 4: Milne Jill C., Director

Returned 4,377 shares to the issuer · Disposed of 956,000 Stock Option (Right to Buy) (Disposition to Issuer)

23 Jan 2026 Form 4: Callori Fred, Director

Disposed of 77,249 Stock Option (Right to Buy) (Disposition to Issuer)

23 Jan 2026 Form 4: Agarwal Sunil, Director

Disposed of 54,750 Stock Option (Right to Buy) (Disposition to Issuer)

23 Jan 2026 S-8 POS
23 Jan 2026 S-8 POS
23 Jan 2026 S-8 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support